# US 2022/0290234 A1 · DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0290234 A1
- Document ID: US20220290234A1
- Status: Published application
- Kind: A1
- Application number: 17/694,404
- Filed: 2022-03-14
- Published: 2022-09-15
- Earliest claimed: 2021-03-15
- Assignees: Illumina, Inc.; Illumina Cambridge Limited
- Applicants: Illumina, Inc.; Illumina Cambridge Limited
- Inventors: Sarah Shultzaberger; Xiaolin Wu; Eric Brustad; Niall Gormley
- Web page: https://patentgrep.com/patent/US20220290234A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C07H 19/16: Purine radicals
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Y 201/01003: Thetin--homocysteine S-methyltransferase (2.1.1.3)
- C12Y 201/01037: DNA (cytosine-5-)-methyltransferase (2.1.1.37)
- C12Y 204/00: Glycosyltransferases (2.4)
- C12Y 204/01027: DNA beta-glucosyltransferase (2.4.1.27)
- C12Y 302/02029: Thymine-DNA glycosylase (3.2.2.29)
- C12Y 305/04005: Cytidine deaminase (3.5.4.5)
- C12Q 2600/154: Methylation markers
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Examples provided herein are related to detecting methylcytosine and its derivatives using S-adenosyl-L-methionine analogs (xSAMs). Compositions and methods for performing such detection are disclosed. A target polynucleotide may include cytosine (C) and methylcytosine (mC). The method may include (a) protecting the C in the target polynucleotide from deamination; and (b) after step (a), deaminating the mC in the target polynucleotide to form thymine (T). Protecting the C from deamination may include adding a protective group to the 5 position of the C, e.g., using a methyltransferase enzyme that adds the first protective group from an xSAM.

## Claims

### Claim 1

A method of modifying a target polynucleotide, the target polynucleotide comprising cytosine (C) and methylcytosine (mC), the method comprising:
(a) protecting the C in the target polynucleotide from deamination;
(b) after step (a), deaminating the mC in the target polynucleotide to form thymine (T).

### Claim 2 (depends on 1)

The method of claim 1, wherein protecting the C from deamination comprises adding a first protective group to the 5 position of the C.

### Claim 3 (depends on 2)

The method of claim 2, wherein a first methyltransferase enzyme adds the first protective group to the 5 position of the C.

### Claim 4 (depends on 3)

The method of claim 3, wherein the first methyltransferase enzyme adds the first protective group from an S-adenosyl-L-methionine analog (xSAM) having the structure:
where X includes the first protective group and a methylene group via which the first protective group is coupled to the sulfonium ion (S+).

### Claim 5 (depends on 2)

The method of claim 2, wherein the first methyltransferase enzyme is selected from the group consisting of: DNMT1, DNMT3A, DNMT3B, dam, and CpG (M.SssI).

### Claim 6 (depends on 2)

The method of claim 2, wherein the first protective group comprises an alkyne group, a carboxyl group, an amino group, a hydroxymethyl group, an isopropyl group, or a dye.

### Claim 7 (depends on 2)

The method of claim 2, wherein the methyl group of mC inhibits addition of X to the 5 position of the mC.

### Claim 8 (depends on 1)

The method of claim 1, wherein a cytidine deaminase enzyme deaminates the mC.

### Claim 9 (depends on 8)

The method of claim 8, wherein X fits within the first methyltransferase enzyme and inhibits activity of the cytidine deaminase enzyme.

### Claim 10 (depends on 8)

The method of claim 8, wherein the cytidine deaminase enzyme comprises APOBEC.

### Claim 11 (depends on 10)

The method of claim 10, wherein the APOBEC is selected from the group consisting of: APOBEC1, APOBEC2, APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3E, APOBEC3F, APOBEC3G, APOBEC3H, and APOBEC4.

### Claim 12 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises hydroxymethylcytosine (hmC), and step (b) comprises deaminating the hmC in the target polynucleotide to form hydroxythymine (hT).

### Claim 13 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises hydroxymethylcytosine (hmC), the method further comprising:
(c) before step (b), protecting the hmC in the target polynucleotide from deamination.

### Claim 14 (depends on 13)

The method of claim 13, wherein step (c) is performed after step (a).

### Claim 15 (depends on 13)

The method of claim 13, wherein protecting the hmC from deamination comprises adding a second protective group to the hydroxymethyl group of the hmC.

### Claim 16 (depends on 15)

The method of claim 15, wherein an enzyme adds the second protective group to the hydroxymethyl group of the hmC.

### Claim 17 (depends on 16)

The method of claim 16, wherein the enzyme is selected from the group consisting of: β-glucosyltransferase (βGT) and β-arabinosyltransferase (βAT).

### Claim 18 (depends on 15)

The method of claim 15, wherein the second protective group comprises a sugar.

### Claim 19 (depends on 13)

The method of claim 13, comprising performing steps (a) and (b) on a first sample including the target polynucleotide, and performing steps (a), (b), and (c) on a second sample including the target polynucleotide.

### Claim 20 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises formylcytosine (fC), wherein the formyl group of the fC inhibits deamination of the fC during step (b).

### Claim 21 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises formylcytosine (fC), the method further comprising:
(d) before step (b), converting the fC to an unprotected C that is deaminated during step (b) to form uracil (U).

### Claim 22 (depends on 21)

The method of claim 21, wherein a thymine deglycosylase enzyme replaces the base of fC with C.

### Claim 23 (depends on 21)

The method of claim 21, comprising performing steps (a) and (b) on a first sample including the target polynucleotide, and performing steps (a), (b), and (d) on a third sample including the target polynucleotide.

### Claim 24 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises carboxylcytosine (caC), wherein the carboxyl group of the caC inhibits deamination of the fC during step (b).

### Claim 25 (depends on 1)

The method of claim 1, wherein the target polynucleotide further comprises carboxylcytosine (caC), the method further comprising:
(e) before step (b), converting the caC to unprotected C that is deaminated during step (b) to form uracil (U).

### Claim 26 (depends on 25)

The method of claim 25, wherein a second methyltransferase enzyme removes the carboxyl group from caC.

### Claim 27 (depends on 25)

The method of claim 25, wherein a thymine deglycosylase enzyme replaces the base of caC with C.

### Claim 28 (depends on 25)

The method of claim 25, comprising performing steps (a) and (b) on a first sample including the target polynucleotide, and performing steps (a), (b), and (e) on a fourth sample including the target polynucleotide.

### Claim 29 (depends on 1)

The method of claim 1, wherein the target polynucleotide comprises DNA.

### Claim 30 (depends on 1)

The method of claim 1, wherein the target polynucleotide comprises first and second adapters.

### Claim 31 (depends on 30)

The method of claim 30, wherein the first and second adapters are added to the target polynucleotide before step (a).

### Claim 32 (depends on 30)

The method of claim 30, wherein the first and second adapters are added to the target polynucleotide after step (b).

### Claim at position 33

-56. (canceled)
